Viewing Study NCT02077959


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-23 @ 5:35 PM
Study NCT ID: NCT02077959
Status: TERMINATED
Last Update Posted: 2023-01-27
First Post: 2014-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed Multiple Myeloma View
None Refractory Multiple Myeloma View